LEO Pharma
About LEO Pharma
LEO Pharma is a global pharmaceutical company focused on dermatology, developing and bringing therapies for skin diseases to patients worldwide. With a long history rooted in Denmark, the company emphasizes a comprehensive portfolio of medical dermatology treatments and a commitment to research and development. Its mission centers on collaboration with healthcare organizations, scientists, and patient groups to advance standards of care and improve patient outcomes. LEO Pharma communicates a strong emphasis on responsible business practices and patient safety as part of its global operations.
Recent News
LEO Pharma to Acquire Replay for Rare Skin Disease Gene Therapy Platform
Apogee’s Royalty Deal With Blackstone Will Fund Pivotal Test in Eczema and More
Pharma and Biotech M&As 2026 Deal Watcher
The Biopharm Brief: Microbiome Fast Track, Leo Pharma Gene Therapy Deal, AAV Automation Advances
VIDEO: ‘New Era of Oral Therapies’ on Horizon in Psoriasis
Chronic Hand Eczema Linked to High Costs, Corticosteroid Overuse
Lilly Wins New FDA Approval for Eczema Drug Ebglyss